This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morrisett, J. D. Articles by Insull, W. Search for Related Content PubMed PubMed Citation Articles by Morrisett, J. D. Articles by Insull, W., Jr Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Carotid Artery Disease Coronary Artery Disease

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1563.)
© 2001 American Heart Association, Inc.

Editorials

Evaluating Atherosclerotic Lesions by Magnetic Resonance Imaging

From Dimensional to Compositional Quantitation

Joel D. Morrisett; William Insull, Jr

From the Department of Medicine, Baylor College of Medicine, Houston, Tex.

Correspondence to Dr. Joel D. Morrisett, Baylor College of Medicine, Methodist Hospital, Departments of Medicine and Biochemistry, Brown-Fondren Bldg, A601, Houston, TX 77030. E-mail morriset@bcm.tmc.edu

The article by Zhao et al¹ is the first definitive study to describe the use of high-resolution MRI to monitor the effects of intensive drug treatment on the dimensions and composition of atherosclerotic plaques in human carotid arteries. (An earlier brief rapid communication by Corti and coworkers² described the effect of lipid-lowering therapy on carotid and aortic vessel dimensions but not plaque composition.) In this small case-control study, eight untreated patients with coronary artery disease were compared with eight patients treated for 10 years with triple lipid–lowering therapy (two carotids each). From the MR image slice that showed the largest plaque area in each carotid, the authors made both dimensional (total area, lumen area, and wall area) and compositional (area occupied by lipid deposits, fibrous tissue, and calcification) measurements. None of the dimensional measurements were significantly different in the two groups. Only the plaque lipid core areas were significantly reduced by lipid therapy (P=0.01), although calcium content tended to be higher in treated patients. However, when the carotids were stratified according to their percent luminal area reduction, the upper tertile (n=12 with 66% to 83% reduction) was significantly different from the other lower tertiles with respect to carotid wall area (P<0.01), lumen area (P<0.01), fibrous area (P<0.05), calcified area (P<0.1), and calcified/lipid-rich area (P<0.1).

See article, page 1623

Although the lack of statistically significant differences for these parameters in the total, unstratified group is disappointing, this problem may . . . [Full Text of this Article]

This article has been cited by other articles:

				R. L. Wolf, S. L. Wehrli, A. M. Popescu, J. H. Woo, H. K. Song, A. C. Wright, E. R. Mohler III, J. D. Harding, E. L. Zager, R. M. Fairman, et al. Mineral Volume and Morphology in Carotid Plaque Specimens Using High-Resolution MRI and CT Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1729 - 1735. [Abstract] [Full Text] [PDF]

				F. M. Yatsu and J. D. Morrisett Carotid Intima-Media Thickness in Familial Combined Hyperlipidemia and LDL Size Stroke, May 1, 2002; 33(5): 1174 - 1175. [Full Text] [PDF]